CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asato, F.
Right arrow Articles by Kanai, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asato, F.
Right arrow Articles by Kanai, A.
Canadian Journal of Anesthesia 48:379-382 (2001)
© Canadian Anesthesiologists' Society, 2001

Regional Anesthesia and Pain

Sensory blockade of S3 dermatome prevents pain during bladder catheterization

Fumio Asato, MD PhD and Akifumi Kanai, MD

From the Department of Anesthesiology, Kitasato University School of Medicine, Kanagawa, Japan.

Address correspondence to: Dr. Fumio Asato, Department of Anesthesiology, Kitasato University School of Medicine, Kanagawa 228-8555, Japan. Phone: 81-42-778-8616; Fax: 81-42-778-8441; E-mail: fasato{at}med.kitasato-u.ac.jp

Purpose: We often encounter patients who do not complain of pain on undergoing invasive urogenital or rectal procedures, despite incomplete epidural blockade of sacral cutaneous sensation. To clarify whether or not urethral pain is blocked faster than sacral cutaneous sensation during lumbar epidural anesthesia, we investigated the correlation between occurrence of urethral pain and loss of cold sensation in the S1–3 dermatomes.

Methods: In 46 gynecological patients, Group A (n=22) received 15 ml of 2% mepivacaine via an epidural catheter inserted cephaladly. Group B (n=24) received 5 ml of 2% mepivacaine directly in the epidural needle directed caudally and 10 ml of 2% mepivacaine via the epidural catheter inserted cephaladly. A Foley catheter was inserted into the urethra 30 min after the injection.

Results: Urethral pain, which was defined as a pained facial expression and/or complaint of pain, was observed in seven patients in Group A, and none in Group B. The caudad level of epidural blockade was significantly lower in patients without urethral pain (S3, median) than with urethral pain (L4) (P <0.05). In 39 patients without urethral pain, 19 (49%) experienced loss of cold sensation in the S1 dermatome, 27 (69%) in the S2 and 38 (97%) in the S3 25 min after the injection.

Conclusion: Blockade of urethral visceral pain often occurs before complete sacral somatosensory blockade, and S3 somatosensory blockade is the important sacral level as an indicator of successful urethral sensory blockade.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.